Investitionsbank des Landes Brandenburg

Dryad Networks GmbH, doing business as Dryad, provides ultra fire detection and health and growth monitoring solutions for public and private forests. It offers sensor nodes, distributed gateways, and a monitoring and analytics platform. Dryad Networks GmbH was formerly known as Eywa Networks GmbH. The company was incorporated in 2020 and is based in Berlin, Germany with an additional office location in Eberswalde, Germany.

We make financial planning and sustainable investing as easy as possible for the mass market

Dryad Networks GmbH, doing business as Dryad, provides ultra fire detection and health and growth monitoring solutions for public and private forests. It offers sensor nodes, distributed gateways, and a monitoring and analytics platform. Dryad Networks GmbH was formerly known as Eywa Networks GmbH. The company was incorporated in 2020 and is based in Berlin, Germany with an additional office location in Eberswalde, Germany.

ScaleHub, a Managed Service Hub for AI data labeling and data processing best practices delivers super-human quality data - at scale. ScaleHub's solution is HIPAA compliant, ISO 27001:2013 certified and GdPR compliant.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in the development of smartphone microscopes equipped with integrated image recognition technology. The company utilizes machine learning and artificial intelligence to transition traditional laboratory image analysis to a cloud-based platform. Oculyze's flagship product, a yeast cell counter, is designed for breweries and wineries, allowing users to capture images through a connected microscope and analyze them in real time using advanced image recognition algorithms. This innovative approach has gained traction among yeast labs globally. Additionally, Oculyze has introduced the MUH product for on-site diagnosis of subclinical endometritis in cows. The company aims to expand its cloud-based image recognition capabilities to various applications, including blood and sperm counts, parasite detection, and asbestos analysis. Oculyze offers solutions as either custom systems for specific applications or through APIs and apps that enhance existing laboratory equipment.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in the development of smartphone microscopes equipped with integrated image recognition technology. The company utilizes machine learning and artificial intelligence to transition traditional laboratory image analysis to a cloud-based platform. Oculyze's flagship product, a yeast cell counter, is designed for breweries and wineries, allowing users to capture images through a connected microscope and analyze them in real time using advanced image recognition algorithms. This innovative approach has gained traction among yeast labs globally. Additionally, Oculyze has introduced the MUH product for on-site diagnosis of subclinical endometritis in cows. The company aims to expand its cloud-based image recognition capabilities to various applications, including blood and sperm counts, parasite detection, and asbestos analysis. Oculyze offers solutions as either custom systems for specific applications or through APIs and apps that enhance existing laboratory equipment.

ODE.Systems provides users, a fun and sustainable decision and evaluation tool. Ode.systems provides a state of the art combination of a convenient and fun system including comprehensive scientific based knowledge and collected data to ease the process. Shared processes resulting in better decisions followed by elevated conscious decision making process. Social Impact Start-up Elevator Pitch https://youtu.be/OjDyxoXA1Oc, 60 sec.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in the development of smartphone microscopes equipped with integrated image recognition technology. The company utilizes machine learning and artificial intelligence to transition traditional laboratory image analysis to a cloud-based platform. Oculyze's flagship product, a yeast cell counter, is designed for breweries and wineries, allowing users to capture images through a connected microscope and analyze them in real time using advanced image recognition algorithms. This innovative approach has gained traction among yeast labs globally. Additionally, Oculyze has introduced the MUH product for on-site diagnosis of subclinical endometritis in cows. The company aims to expand its cloud-based image recognition capabilities to various applications, including blood and sperm counts, parasite detection, and asbestos analysis. Oculyze offers solutions as either custom systems for specific applications or through APIs and apps that enhance existing laboratory equipment.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in the development of smartphone microscopes equipped with integrated image recognition technology. The company utilizes machine learning and artificial intelligence to transition traditional laboratory image analysis to a cloud-based platform. Oculyze's flagship product, a yeast cell counter, is designed for breweries and wineries, allowing users to capture images through a connected microscope and analyze them in real time using advanced image recognition algorithms. This innovative approach has gained traction among yeast labs globally. Additionally, Oculyze has introduced the MUH product for on-site diagnosis of subclinical endometritis in cows. The company aims to expand its cloud-based image recognition capabilities to various applications, including blood and sperm counts, parasite detection, and asbestos analysis. Oculyze offers solutions as either custom systems for specific applications or through APIs and apps that enhance existing laboratory equipment.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in the development of smartphone microscopes equipped with integrated image recognition technology. The company utilizes machine learning and artificial intelligence to transition traditional laboratory image analysis to a cloud-based platform. Oculyze's flagship product, a yeast cell counter, is designed for breweries and wineries, allowing users to capture images through a connected microscope and analyze them in real time using advanced image recognition algorithms. This innovative approach has gained traction among yeast labs globally. Additionally, Oculyze has introduced the MUH product for on-site diagnosis of subclinical endometritis in cows. The company aims to expand its cloud-based image recognition capabilities to various applications, including blood and sperm counts, parasite detection, and asbestos analysis. Oculyze offers solutions as either custom systems for specific applications or through APIs and apps that enhance existing laboratory equipment.

ScaleHub, a Managed Service Hub for AI data labeling and data processing best practices delivers super-human quality data - at scale. ScaleHub's solution is HIPAA compliant, ISO 27001:2013 certified and GdPR compliant.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in the development of smartphone microscopes equipped with integrated image recognition technology. The company utilizes machine learning and artificial intelligence to transition traditional laboratory image analysis to a cloud-based platform. Oculyze's flagship product, a yeast cell counter, is designed for breweries and wineries, allowing users to capture images through a connected microscope and analyze them in real time using advanced image recognition algorithms. This innovative approach has gained traction among yeast labs globally. Additionally, Oculyze has introduced the MUH product for on-site diagnosis of subclinical endometritis in cows. The company aims to expand its cloud-based image recognition capabilities to various applications, including blood and sperm counts, parasite detection, and asbestos analysis. Oculyze offers solutions as either custom systems for specific applications or through APIs and apps that enhance existing laboratory equipment.

Oculyze GmbH, founded in 2016 and based in Wildau, Brandenburg, Germany, specializes in the development of smartphone microscopes equipped with integrated image recognition technology. The company utilizes machine learning and artificial intelligence to transition traditional laboratory image analysis to a cloud-based platform. Oculyze's flagship product, a yeast cell counter, is designed for breweries and wineries, allowing users to capture images through a connected microscope and analyze them in real time using advanced image recognition algorithms. This innovative approach has gained traction among yeast labs globally. Additionally, Oculyze has introduced the MUH product for on-site diagnosis of subclinical endometritis in cows. The company aims to expand its cloud-based image recognition capabilities to various applications, including blood and sperm counts, parasite detection, and asbestos analysis. Oculyze offers solutions as either custom systems for specific applications or through APIs and apps that enhance existing laboratory equipment.

Until now, online shops haven't been able to offer the level of personalized fashion advice available in brick-and-mortar stores. Inspora brings fashion guidance to every online shop, with a digital shopping assistant that automatically leads each individual customer through the shopping process - from finding the right style to searching for outfits and products to checking out. The result: satisfied customers and more sales for online shops. Brands and retailers can integrate Inspora into their online shop as a chat widget, tailored exclusively to their functional requirements, product range and branding. Inspora is the first solution developed specifically for the fashion industry, using artificial intelligence and chatbot technology, that draws on the digitalized knowledge of hundreds of human personal stylists, allowing fully automatic fashion advice to be offered for the first time. The German Federal Ministry for Economic Affairs awarded Inspora with the EXIST Business Start-up Grant for its innovative technology. - Tagesspiegel: "What on earth am I going to wear? Inspora provides fashion-conscious women with the answer to this question with the help of artificial intelligence.” - Berliner Zeitung: “Chatting with Inspora is fun and a useful source of inspiration for women of all ages.“ - Handelsblatt: "It took six months to develop the algorithm, which drew on the experience of over 100 human stylists."​ - The Federal Government: "Inspora is in fact a machine. Nevertheless, it is a likeable fashion fanatic and personal assistant – thanks to artificial intelligence (AI)."​

Emperra GmbH E-Health Technologies, founded in 2008 and based in Potsdam, Germany, specializes in the development of telemedical products aimed at managing diabetes. The company focuses on GSM and web-based solutions that facilitate the tracking, monitoring, and transmission of crucial diagnostic and therapeutic data for diabetic patients, including insulin doses, blood sugar levels, and carbohydrate intake. Emperra's innovative diabetes monitoring system integrates a Bluetooth-enabled insulin pen and a wireless blood glucose meter, allowing healthcare professionals to effectively monitor their patients' conditions and adjust treatments as necessary.

Wirkaufens is a privately held company that sell used cell phones and electronics online.

Clipnow creates virtual 360° real estate rounds as well as spoken, automated videos for website and portals.

EBS Technologies GmbH, founded in 2007 and headquartered in Hennigsdorf, Germany, specializes in developing and commercializing medical devices aimed at treating neurologically induced impairments, particularly visual field loss. The company offers EBS Therapy, a non-invasive optic nerve stimulation treatment that utilizes low-voltage electrical currents to promote neuroregeneration and neuroprotection. This therapy targets conditions resulting from stroke, traumatic brain injury, and glaucoma, among others. With over 15 years of research and clinical experience involving more than 1,200 patients, EBS Technologies has demonstrated through double-blind, randomized studies and clinical observations that its therapy can help partially restore vision in affected individuals. The company received the CE Mark for its stimulation device in 2013 and commenced commercial treatments in 2014. Currently, there are eight EBS Treatment centers operating across Germany, with plans to expand the network further.